Al-Azhar faculty of medicine
Cairo, 12546, Egypt
NCT Number: NCT06687187
A study comparing the effect of two doses of neostigmine on the gastric residual volume in critically ill patients on enteral feeding.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Observational
Cairo, 12546, Egypt
Participants were categorized into three groups: Group I and Group II received neostigmine 1 mg and 2 mg, respectively, and a control group received 10 ml of normal saline. All participants received an intravenous administration of 10 mg of metoclopramide. GRV was measured every 3 hours before enteral feeding. aspiration through nasogastric (NG) or orogastric (OG) tubes was done before the next due bolus of feeding.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
two groups (Group I, n= 41) and (Group II, n= 43) received varying doses of neostigmine (1 mg and 2 mg respectively
Time frame: december 2022 to may 2024
The risk of aspiration in ICU patients on enteral feeding via vaso-gastric or oro-hastric tubes
Zulekha Hospitals
Other
Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients Under Enteral Feeding; a Comparative Controlled Randomized Trial
Acronym: Gastric
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05500196
Deglutition Disorders, Digestive System Diseases
Hyderabad, Telangana, India
View Trial DetailsNCT05320796
Body Weight, Deglutition Disorders
Schlieren, Switzerland
View Trial DetailsNCT05556824
Deglutition Disorders, Digestive System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07722663
Deglutition Disorders, Digestive System Diseases
San Donato Milanese, Milan, Italy
View Trial Details